Impact of active surveillance and decolonization strategies for methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit

J Perinatol. 2024 May;44(5):724-730. doi: 10.1038/s41372-024-01902-w. Epub 2024 Feb 13.

Abstract

Objective: To assess the impact of active surveillance and decolonization strategies on methicillin-resistant Staphylococcus aureus (MRSA) infection rates in a NICU.

Study design: MRSA infection rates were compared before (2014-2016) and during (2017-2022) an active surveillance program. Eligible infants were decolonized with chlorohexidine gluconate (CHG) bathing and/or topical mupirocin. Successful decolonization and rates of recolonization were assessed.

Results: Fifty-two (0.57%) of 9 100 hospitalized infants had invasive MRSA infections from 2014 to 2022; infection rates declined non-significantly. During the 6-year surveillance program, the risk of infection was 16.9-times [CI95 8.4, 34.1] higher in colonized infants than uncolonized infants. Those colonized with mupirocin-susceptible MRSA were more likely successfully decolonized (aOR 9.7 [CI95 4.2, 22.5]). Of 57 infants successfully decolonized who remained hospitalized, 34 (60%) became recolonized.

Conclusions: MRSA infection rates did not significantly decline in association with an active surveillance and decolonization program. Alternatives to mupirocin and CHG are needed to facilitate decolonization.

MeSH terms

  • Anti-Bacterial Agents* / administration & dosage
  • Anti-Bacterial Agents* / therapeutic use
  • Anti-Infective Agents, Local / administration & dosage
  • Anti-Infective Agents, Local / therapeutic use
  • Baths
  • Chlorhexidine* / administration & dosage
  • Chlorhexidine* / analogs & derivatives
  • Chlorhexidine* / therapeutic use
  • Cross Infection* / epidemiology
  • Cross Infection* / microbiology
  • Cross Infection* / prevention & control
  • Female
  • Humans
  • Infant, Newborn
  • Intensive Care Units, Neonatal*
  • Male
  • Methicillin-Resistant Staphylococcus aureus* / isolation & purification
  • Mupirocin* / administration & dosage
  • Mupirocin* / therapeutic use
  • Staphylococcal Infections* / drug therapy
  • Staphylococcal Infections* / prevention & control

Substances

  • Mupirocin
  • Chlorhexidine
  • chlorhexidine gluconate
  • Anti-Bacterial Agents
  • Anti-Infective Agents, Local